Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001739815-21-000001
Filing Date
2021-12-01
Accepted
2021-12-01 15:26:59
Documents
1
Effectiveness Date
2021-12-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7111
  Complete submission text file 0001739815-21-000001.txt   8126
Mailing Address 1029 CATHCART WAY STANFORD CA 94305
Business Address 1029 CATHCART WAY STANFORD CA 94305 650-856-1971
Fountain Therapeutics, Inc. (Filer) CIK: 0001739815 (see all company filings)

EIN.: 824181770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-423146 | Film No.: 211462728